0:00
17:37
Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.
Weitere Episoden von „Australian Prescriber Podcast“
Verpasse keine Episode von “Australian Prescriber Podcast” und abonniere ihn in der kostenlosen GetPodcast App.